Synkrino Biotherapeutics
Latest round
- Seed
Last raised
- Jul 2018
Total raised
- $1M
Investors
- 1
About Synkrino Biotherapeutics
Founded in 2018 and based in California, US, Synkrino Biotherapeutics, Inc. offers an AI-powered biotech platform that discovers and develops drug targets from the immune system of patients.
Who invested in Synkrino Biotherapeutics
1 investor across 1 round
See all investors in Synkrino Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 1, 2018
Amount
$1M
Investors
Questions about Synkrino Biotherapeutics
Who invested in Synkrino Biotherapeutics?
Synkrino Biotherapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synkrino Biotherapeutics raised?
Synkrino Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synkrino Biotherapeutics last raise money?
Synkrino Biotherapeutics's most recent round on record is a Seed, in Jul 2018.
What does Synkrino Biotherapeutics do?
Founded in 2018 and based in California, US, Synkrino Biotherapeutics, Inc.
Where is Synkrino Biotherapeutics headquartered?
Synkrino Biotherapeutics is headquartered in Berkeley, US.
Which VCs invest in companies like Synkrino Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synkrino Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Synkrino Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.